IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 1 filers reported holding IMMUNE DESIGN CORP in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $61,000 | 0.0% | 10,290 | -78.1% | 0.00% | – |
| Q4 2018 | $61,000 | -41.9% | 46,958 | +54.7% | 0.00% | – |
| Q3 2018 | $105,000 | -50.5% | 30,358 | -35.1% | 0.00% | – |
| Q2 2018 | $212,000 | +360.9% | 46,754 | +231.9% | 0.00% | – |
| Q1 2018 | $46,000 | -49.5% | 14,085 | -39.8% | 0.00% | – |
| Q4 2017 | $91,000 | -46.8% | 23,416 | +42.2% | 0.00% | – |
| Q3 2017 | $171,000 | +40.2% | 16,463 | +31.5% | 0.00% | – |
| Q2 2017 | $122,000 | +17.3% | 12,523 | -17.9% | 0.00% | – |
| Q1 2017 | $104,000 | +181.1% | 15,246 | +123.3% | 0.00% | – |
| Q4 2016 | $37,000 | +640.0% | 6,828 | +1079.3% | 0.00% | – |
| Q3 2016 | $5,000 | -58.3% | 579 | -59.3% | 0.00% | – |
| Q2 2016 | $12,000 | -82.9% | 1,422 | -59.5% | 0.00% | – |
| Q4 2015 | $70,000 | – | 3,507 | +8667.5% | 0.00% | – |
| Q3 2015 | $0 | -100.0% | 40 | -96.6% | 0.00% | – |
| Q2 2015 | $24,000 | – | 1,174 | +7237.5% | 0.00% | – |
| Q1 2015 | $0 | -100.0% | 16 | -87.6% | 0.00% | – |
| Q3 2014 | $2,000 | – | 129 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Svennilson Peter | 6,642,942 | $8,636,000 | 7.61% |
| Versant Venture Management, LLC | 2,208,210 | $2,870,673,000 | 1.42% |
| BVF INC/IL | 5,185,383 | $6,741,000 | 0.88% |
| EcoR1 Capital, LLC | 5,603,191 | $7,284,000 | 0.73% |
| Abingworth LLP | 352,300 | $458,000 | 0.42% |
| Bain Capital Public Equity Management, LLC | 892,061 | $1,160,000 | 0.11% |
| ALGERT GLOBAL LLC | 92,591 | $120,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 41,068 | $53,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 136,468 | $177,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 27,122 | $35,000 | 0.01% |